Mechanism of Action of Ocrelizumab in Multiple Sclerosis
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Ocrelizumab (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 21 Nov 2017 New trial record
Latest Information Update: 05 Nov 2021